This website uses cookies to enhance the user experience.
PATOGEN AS

PATOGEN AS985 525 331

Research
Limited company
Rasmus Rønnebergs gate 21 6002 ÅLESUND, Norge

PATOGEN AS

PatoGen AS - a fish health company
PatoGen has a long standing record within fish health and has a lasting ambition to be a major contributor to more sustainable production of fish.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
22 years
since Mar 24, 2003
Type
Limited company
VAT registered
Yes
Number of employees
54

Ownership

Number of shares and share classes
666,667
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
107,757,063
NOK
Annual total result 2024
3,665,496
NOK
Total equity 2024
44,217,861
NOK
Last update: Jul 14, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
Alternate Member-
ResignedAlternate Member-

Others

NameRoleShares
P
PKF REVISJON AS
Auditor-
Last update: Jun 3, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
666,667
100 %

Shares owned by the PATOGEN AS

NameShare classTotal number of sharesShare
P
PATOGEN NORD AS
Ordinary shares
60
60 %
K
KARKANT AS
Ordinary shares
30,000
50 %
N
NCE AQUACULTURE AS
Ordinary shares
10
9.09 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 62,895,043
    Operating profit 2023: NOK 53,971,451
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
107,757,063
105,982,758
93,191,152
90,953,803
Annual Total Result
3,665,496
12,107,999
6,500,784
-4,350,263
Total assets
64,022,671
68,715,935
66,098,868
65,711,562
Total liabilities
19,804,810
28,163,570
19,234,916
25,348,394
Total equity
44,217,861
40,552,365
46,863,952
40,363,168

P&L

Year2024202320222021
Total operating income
107,757,063
105,982,758
93,191,152
90,953,803
Total operating costs
104,093,343
96,123,487
85,064,005
98,805,369
Operating result
3,663,720
9,859,271
8,127,147
-7,851,566
Financial income/costs
1,172,622
1,506,965
4,859
1,616,123
Profit before tax
4,836,342
11,366,236
8,132,006
-6,235,443
Total tax & extraordinary income/cost
1,170,846
-741,763
1,631,222
-1,885,180
Annual Total Result
3,665,496
12,107,999
6,500,784
-4,350,263

Balance overview

Year2024202320222021
Total fixed assets
13,364,092
16,808,296
24,047,713
18,802,858
Total current assets
50,658,579
51,907,639
42,051,155
46,908,704
Total assets
64,022,671
68,715,935
66,098,868
65,711,562
Short term debt
19,804,810
28,163,570
19,234,916
18,067,268
Long term debt
0
0
0
7,281,126
Total liabilities
19,804,810
28,163,570
19,234,916
25,348,394
Contributed capital
6,904,787
6,904,787
6,904,787
6,904,787
Retained earnings
37,313,074
33,647,578
39,959,165
33,458,381
Total equity
44,217,861
40,552,365
46,863,952
40,363,168
Total equity and liabilities
64,022,671
68,715,935
66,098,868
65,711,562

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology